Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Learn more about REXULTI for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

FDA advisors to weigh use of Rexulti for Alzheimer's agitation

Frontiers Understanding neuropsychiatric symptoms in Alzheimer's disease: challenges and advances in diagnosis and treatment

Treatments for Behavior Alzheimer's Association

FDA Approves Rexulti For Agitation Associated With Dementia Due To Alzheimer's

A silent struggle: Caregiving for a patient with agitation associated with dementia due to Alzheimer's disease - STAT

FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients

Otsuka and Lundbeck Issue Statement on REXULTI for Alzheimer's

US FDA approves Rexulti as first drug for agitation in Alzheimer's dementia

Researcher finds help for Alzheimer's-associated agitation with new FDA-approved treatment

Otsuka Pharmaceutical and Lundbeck present positive results showing reduced agitation in patients with Alzheimer's dementia treated with brexpiprazole at the 2022 Alzheimer's Association International Conference